Lipid Modification Database
Tag Content
LipidDB ID
LipidDB-9606-00996
Entry Name
UniProt Accession
Theoretical PI
7.51
Molecular Weight
17005.98
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
Transforming growth factor alpha
Protein Synonyms/Alias
TGF-alpha; EGF-like TGF; ETGF; TGF type 1;
Gene Name
TGFA
Gene Synonyms/Alias
Created Date
21-JUL-1986
 Lipid Modification Sites 
 Position   Sequence Form   Peptide   References   Modification Type 
153
Canonical
LLKGRTACCHSETVV
[1]
S-Palmitoylation
154
Canonical
LKGRTACCHSETVV*
[1]
S-Palmitoylation
Organism
Homo sapiens (Human)
NCBI Taxa ID
9606
Reference
[1] Shum L, Turck CW, Derynck R. Cysteines 153 and 154 of transmembranetransforming growth factor-alpha are palmitoylated and mediate cytoplasmicprotein association. J Biol Chem. 1996 Nov 8;271(45):28502-8.[PMID:8910478]
Functional Description
TGF alpha is a mitogenic polypeptide that is able to bind to the EGF receptor/EGFR and to act synergistically with TGF beta to promote anchorage-independent cell proliferation in soft agar.
Sequence Annotation
Topological domain: 24 98 Extracellular.
Transmembrane: 99 124 Helical.
Topological domain: 125 160 Cytoplasmic.
Domain: 43 83 EGF-like.
Protein Length
160 AA.
Protein Sequence
(Canonical)
MVPSAGQLAL FALGIVLAAC QALENSTSPL SADPPVAAAV VSHFNDCPDS HTQFCFHGTC  60
RFLVQEDKPA CVCHSGYVGA RCEHADLLAV VAASQKKQAI TALVVVSIVA LAVLIITCVL  120
IHCCQVRKHC EWCRALICRH EKPSALLKGR TACCHSETVV                        160
FASTA
(Canonical)
>LipidDB-9606-00996|P01135
MVPSAGQLALFALGIVLAACQALENSTSPLSADPPVAAAVVSHFNDCPDSHTQFCFHGTC
RFLVQEDKPACVCHSGYVGARCEHADLLAVVAASQKKQAITALVVVSIVALAVLIITCVL
IHCCQVRKHCEWCRALICRHEKPSALLKGRTACCHSETVV
Gene Ontology
GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL
GO:0009986; C:cell surface; IDA:BHF-UCL
GO:0031410; C:cytoplasmic vesicle; IDA:BHF-UCL
GO:0005615; C:extracellular space; IDA:BHF-UCL
GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW
GO:0005634; C:nucleus; IEA:Ensembl
GO:0048471; C:perinuclear region of cytoplasm; IDA:BHF-UCL
GO:0005886; C:plasma membrane; NAS:ProtInc
GO:0005154; F:epidermal growth factor receptor binding; IDA:UniProtKB
GO:0008083; F:growth factor activity; IDA:HGNC
GO:0004708; F:MAP kinase kinase activity; IDA:HGNC
GO:0000187; P:activation of MAPK activity; IDA:HGNC
GO:0001525; P:angiogenesis; IEA:Ensembl
GO:0008283; P:cell proliferation; TAS:ProtInc
GO:0007173; P:epidermal growth factor receptor signaling pathway; IEA:Ensembl
GO:0060749; P:mammary gland alveolus development; IEA:Ensembl
GO:0000165; P:MAPK cascade; IDA:GOC
GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl
GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW
GO:0045741; P:positive regulation of epidermal growth factor-activated receptor activity; IDA:HGNC
GO:0050679; P:positive regulation of epithelial cell proliferation; IDA:HGNC
GO:0045840; P:positive regulation of mitosis; IDA:HGNC
GO:0042493; P:response to drug; IEA:Ensembl
GO:0042060; P:wound healing; IEA:Ensembl
Interpro
InterPro; IPR000742; EG-like_dom
InterPro; IPR013032; EGF-like_CS
InterPro; IPR015497; EGF_rcpt_ligand
Pfam
SMART
SMART; SM00181; EGF;
PROSITE
PROSITE; PS00022; EGF_1;
PROSITE; PS01186; EGF_2;
PROSITE; PS50026; EGF_3;
PRINTS